Abstract
Retrovirus vectors derived from moloney murine leukemia virus (MoMLV) were the first class of viral vectors developed for gene therapy. They have been extensively used in clinical trials, particularly in ex vivo transduction of hematopoietic stem cells. Although there is a vast experience acquired with retroviruses, their manufacturing is still a difficult task due to the low cell productivities and inherent instability of the infective virus. These viral vectors are most commonly produced using stable producer cell lines in adherent monolayer culture systems. In order to obtain high transduction efficiencies and low toxicity in clinical applications, the viral preparations should be purified, concentrated, and well characterized to attain stringent quality specifications. This chapter describes currently used protocols for manufacturing retroviruses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blaese, R. M., K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J. J. Greenblatt, S. A. Rosenberg, H. Klein, M. Berger, C. A. Mullen, W. J. Ramsey, L. Muul, R. A. Morgan and W. F. Anderson (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270, 475–480.
Andrew Mountain (2000) Gene Therapy: the first decade. TIBTECH 18, 119–128.
Thomas, C.E., Ehrhardt, A., and Kay, M.A. (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4, 346–358.
Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, RH., Bregni, M., Marktel, S., Valsecchi, MG., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., Roncarolo, M.G. (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 360, 447–58.
Roth, J. A. and R. J. Cristiano (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89, 21–39.
Cruz, P.E., Coroadinha, A.S., Rodrigues, T., and Hauser, H. (2008) Production of Retroviral Vectors: from the producer cell to the final product, In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies Taylor & Francis eds. (CRC Press) pp. 17–32.
Merten, O.-W. (2004) State-of-the-art of the production of retroviral vectors. J Gene Med 6, S105–124.
Coroadinha, A.S., Schucht, R., Gama-Norton, L., Wirth, D., Hauser, H., and Carrondo, M.J.T. (2006) The use of recombinase cassette exchange in retroviral vector producer cell lines: predictability and efficiency in transgene exchange. J. Biotechnol. 124, 457–468.
Schucht, R., Coroadinha, A.S., Zanta-Boussif, M.A., Verhoeyen, E., Carrondo, M.J., Hauser, H., and Wirth, D. (2006) A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther 14, 285–292.
Rodrigues, T., Carrondo, M.J., Alves, P.M., Cruz, P.E. (2007) Purification of retroviral vectors for clinical application: biological implications and technological challenges. J Biotechnol 127, 520–41.
Miller, A.D., Buttimore, C. (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895–2902.
Miller, A.D., et al. (1991) Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220–2224.
Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., Collins, M.K. (1995) High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69, 7430–7436.
Swift, S., Lorens, J., Achacoso, P., Nolan, G.P. (2001) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol., Chapter 10: Unit 10.17C.
Duisit, G., Salvetti, A., Moullier, P., Cosset, F.-L. (1999) Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum Gene Ther, 10, 189–200.
Pizzato, M., Merten, O.W., Blair, E.D., Takeuchi, Y. (2001) Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. Gene Ther., 8, 737–45.
Carmo, M., Peixoto, C., Coroadinha, A.S., Alves, P.M., Cruz, P.E., Carrondo, M.J.T. (2004). Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J Virol Methods 119, 115–119.
Rodrigues, T., Carvalho, A., Carmo, M., Carrondo, M.J.T., Alves, P.M., Cruz, P.E. (2007) Scalable purification process for gene therapy retroviral vectors. J Gene Med 9, 233–243.
Transfiguracion, J., Coelho, H., Kamen, A. (2004) High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein. J Chromatogr B Analyt Technol Biomed Life Sci 813, 167–173.
Schambach, A., Maetzig, T. and BAUM, C. (2008) Retroviral Vectors for Gene and Cell Therapy, In Gene and Cell Therapy: Therapeutic Mechanisms and Strategies Taylor & Francis eds. (CRC Press) pp. 3–15.
Cruz, P.E., Silva, A.S., Roldão, A., Carmo, M., Carrondo, M.J.T., Alves. P.M. (2006) Screening of Novel Excipients for Improving the Stability of Retroviral and Adenoviral Vectors. Biotech. Pro. 22, 568–576.
Carmo, M., Alves, A., Rodrigues, A.F., Coroadinha, A.S., Carrondo, M.J.T., Alves, P.M., Cruz, P.E. (2009) Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer. J Gene Med 11, 670–678.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC 2011
About this protocol
Cite this protocol
Cruz, P.E. et al. (2011). Manufacturing of Retroviruses. In: Merten, OW., Al-Rubeai, M. (eds) Viral Vectors for Gene Therapy. Methods in Molecular Biology, vol 737. Humana Press. https://doi.org/10.1007/978-1-61779-095-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-61779-095-9_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-094-2
Online ISBN: 978-1-61779-095-9
eBook Packages: Springer Protocols